Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe.
| Website: | www.pacb.com |
| Email: | ir@pacificbiosciences.com |
| Main Phone: | +1 650 521-8000 |
| Address: | 1305 O'Brien Drive |
| State: | CA |
| City / Town: | Menlo Park |
| Country: | USA |
| Postal Code: | 94025 |
| Exchange: | NGS |
| CEO: | Michael Hunkapiller |
| Employees: | 456 |
| NAICS: | Analytical Laboratory Instrument Manufacturing(334516) |
| Last Price 7.53 | Change $ -0.17 | Change % -2.21 | Tick N/A |
| Bid 7.47 | Bid Size 1,000.00 | Ask 7.80 | Ask Size 2,100.00 |
| Open 7.64 | High 7.68 | Low 7.50 | Prev Close 7.70 |
| Last Trade | Volume 4.1 mi | 52 Wk Hi 7.84 | 52 Wk Low 2.02 |
| Market Cap 1.1 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 148,901,892.00 | EPS (TTM) -0.73 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 3 | 7 |
| Number of Buys | 3 | 7 |
| Number of Sells | 0 | 0 |
| Net Activity | 137500 | 184061 |
| Last 10 Buys | Shares |
|---|---|
| Michael Phillips | 1,000 |
| Michael Phillips | 1,000 |
| Michael Phillips | 1,000 |
| Kevin P. Corcoran | 1,000 |
| Brian B. Dow | 1,000 |
| Michael Phillips | 1,000 |
| Kevin P. Corcoran | 1,000 |
| William W. Ericson | 1,000 |
| William W. Ericson | 1,000 |
| William W. Ericson | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Michael Phillips | 1,000 |
| Michael Phillips | 1,000 |
| Michael Phillips | 1,000 |
| Michael Phillips | 1,000 |
| Stephen Turner | 1,000 |
| Stephen Turner | 1,000 |
| Stephen Turner | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 4.5 | 5.5 | 5.5 | 4.5 |
| Low Target Price Estimate | 3.25 | 3.25 | 3.25 | 3.25 |
| Mean Target Price Estimate | 3.92 | 4.25 | 4.25 | 3.92 |
| Standard Deviation | 0.63 | 1.15 | 1.15 | 0.63 |
| Date of Most Recent Estimate | 06/04/18 | 05/02/18 | 05/02/18 | 06/04/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-23 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-05-23 |
| SD | Specialized Disclosure Report | 8 | 2018-05-18 |
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2018-05-08 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 134 | 2018-05-02 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 2.33 | 2.33 | 2.33 | 2.33 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
